These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1117 related articles for article (PubMed ID: 26457695)

  • 1. Duchenne Muscular Dystrophy: From Diagnosis to Therapy.
    Falzarano MS; Scotton C; Passarelli C; Ferlini A
    Molecules; 2015 Oct; 20(10):18168-84. PubMed ID: 26457695
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular diagnosis of Duchenne muscular dystrophy.
    Nallamilli BR; Ankala A; Hegde M
    Curr Protoc Hum Genet; 2014 Oct; 83():9.25.1-29. PubMed ID: 25271841
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical trials using antisense oligonucleotides in duchenne muscular dystrophy.
    Koo T; Wood MJ
    Hum Gene Ther; 2013 May; 24(5):479-88. PubMed ID: 23521559
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Mutation-specific treatments for Duchenne muscular dystrophy].
    Matsuo M; Takeshima Y
    Brain Nerve; 2009 Aug; 61(8):915-22. PubMed ID: 19697880
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic analysis of 62 Chinese families with Duchenne muscular dystrophy and strategies of prenatal diagnosis in a single center.
    Zhang J; Ma D; Liu G; Wang Y; Liu A; Li L; Luo C; Hu P; Xu Z
    BMC Med Genet; 2019 Nov; 20(1):180. PubMed ID: 31727011
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeted sequencing of the
    Aravind S; Ashley B; Mannan A; Ganapathy A; Ramesh K; Ramachandran A; Nongthomba U; Shastry A
    Indian J Med Res; 2019 Sep; 150(3):282-289. PubMed ID: 31719299
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Use of Antisense Oligonucleotides for the Treatment of Duchenne Muscular Dystrophy.
    Relizani K; Goyenvalle A
    Methods Mol Biol; 2018; 1687():171-183. PubMed ID: 29067663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular diagnosis of Duchenne/Becker muscular dystrophy: enhanced detection of dystrophin gene rearrangements by oligonucleotide array-comparative genomic hybridization.
    del Gaudio D; Yang Y; Boggs BA; Schmitt ES; Lee JA; Sahoo T; Pham HT; Wiszniewska J; Chinault AC; Beaudet AL; Eng CM
    Hum Mutat; 2008 Sep; 29(9):1100-7. PubMed ID: 18752307
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Genetic Diagnosis and Molecular Therapies for Duchenne Muscular Dystrophy].
    Takeshima Y
    Rinsho Byori; 2015 Oct; 63(10):1194-201. PubMed ID: 26897856
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Next Generation Sequencing approach to molecular diagnosis of Duchenne muscular dystrophy; identification of a novel mutation.
    Ebrahimzadeh-Vesal R; Teymoori A; Azimi-Nezhad M; Hosseini FS
    Gene; 2018 Feb; 644():1-3. PubMed ID: 29246534
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclic Peptides to Improve Delivery and Exon Skipping of Antisense Oligonucleotides in a Mouse Model for Duchenne Muscular Dystrophy.
    Jirka SMG; 't Hoen PAC; Diaz Parillas V; Tanganyika-de Winter CL; Verheul RC; Aguilera B; de Visser PC; Aartsma-Rus AM
    Mol Ther; 2018 Jan; 26(1):132-147. PubMed ID: 29103911
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Designing Effective Antisense Oligonucleotides for Exon Skipping.
    Shimo T; Maruyama R; Yokota T
    Methods Mol Biol; 2018; 1687():143-155. PubMed ID: 29067661
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic diagnosis of Duchenne/Becker muscular dystrophy using next-generation sequencing: validation analysis of DMD mutations.
    Okubo M; Minami N; Goto K; Goto Y; Noguchi S; Mitsuhashi S; Nishino I
    J Hum Genet; 2016 Jun; 61(6):483-9. PubMed ID: 26911353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular Diagnosis of Duchenne Muscular Dystrophy Using Single NGS-Based Assay.
    Nallamilli BRR; Guruju N; Jump V; Liu R; Hegde M
    Curr Protoc; 2023 Feb; 3(2):e669. PubMed ID: 36748823
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A splicing mutation in the DMD gene detected by next-generation sequencing and confirmed by mRNA and protein analysis.
    Roucher Boulez F; Menassa R; Streichenberger N; Manel V; Mallet-Motak D; Morel Y; Michel-Calemard L
    Clin Chim Acta; 2015 Aug; 448():146-9. PubMed ID: 26148721
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative Antisense Screening and Optimization for Exon 51 Skipping in Duchenne Muscular Dystrophy.
    Echigoya Y; Lim KRQ; Trieu N; Bao B; Miskew Nichols B; Vila MC; Novak JS; Hara Y; Lee J; Touznik A; Mamchaoui K; Aoki Y; Takeda S; Nagaraju K; Mouly V; Maruyama R; Duddy W; Yokota T
    Mol Ther; 2017 Nov; 25(11):2561-2572. PubMed ID: 28865998
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel high-throughput immunofluorescence analysis method for quantifying dystrophin intensity in entire transverse sections of Duchenne muscular dystrophy muscle biopsy samples.
    Sardone V; Ellis M; Torelli S; Feng L; Chambers D; Eastwood D; Sewry C; Phadke R; Morgan JE; Muntoni F
    PLoS One; 2018; 13(3):e0194540. PubMed ID: 29579078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Whole dystrophin gene analysis by next-generation sequencing: a comprehensive genetic diagnosis of Duchenne and Becker muscular dystrophy.
    Wang Y; Yang Y; Liu J; Chen XC; Liu X; Wang CZ; He XY
    Mol Genet Genomics; 2014 Oct; 289(5):1013-21. PubMed ID: 24770780
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DMD pseudoexon mutations: splicing efficiency, phenotype, and potential therapy.
    Gurvich OL; Tuohy TM; Howard MT; Finkel RS; Medne L; Anderson CB; Weiss RB; Wilton SD; Flanigan KM
    Ann Neurol; 2008 Jan; 63(1):81-9. PubMed ID: 18059005
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel canine model for Duchenne muscular dystrophy (DMD): single nucleotide deletion in DMD gene exon 20.
    Mata López S; Hammond JJ; Rigsby MB; Balog-Alvarez CJ; Kornegay JN; Nghiem PP
    Skelet Muscle; 2018 May; 8(1):16. PubMed ID: 29843823
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 56.